Anavex Life Sciences Corp.: A High-Risk, High-Reward Bet on CNS Innovation
Anavex is a clinical-stage biopharmaceutical company focused on developing therapies for neurodegenerative and neurodevelopmental disorders, using its proprietary SIGMACEPTOR™ platform to target sigma-1 receptor pathways.